Avidity Biosciences, Inc. — Investor Relations & Filings
Avidity Biosciences, Inc. is a biopharmaceutical company developing a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs). The company's proprietary AOC platform combines the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide-based therapies. This approach is designed to overcome challenges in drug delivery by enabling targeted transport of RNA therapeutics to specific cells and tissues, such as muscle, that were previously inaccessible. Avidity's pipeline is initially focused on developing treatments for rare muscle diseases, with the objective of addressing the underlying genetic drivers of these conditions and expanding into other therapeutic areas.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 - AVIDITY BIOSCIENCES, INC. (0001599901) (Filer) | 2026-02-27 | English | |
| 4 - AVIDITY BIOSCIENCES, INC. (0001599901) (Filer) | 2026-02-27 | English | |
| 4 - AVIDITY BIOSCIENCES, INC. (0001599901) (Filer) | 2026-02-27 | English | |
| 4 - AVIDITY BIOSCIENCES, INC. (0001599901) (Filer) | 2026-02-27 | English | |
| 4 - AVIDITY BIOSCIENCES, INC. (0001599901) (Filer) | 2026-02-27 | English | |
| 4 - AVIDITY BIOSCIENCES, INC. (0001599901) (Filer) | 2026-02-27 | English |
Browse filings by year
10 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Avidity Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30894/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30894 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30894 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30894 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30894}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Avidity Biosciences, Inc. (id: 30894)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.